Analysis of mutations in the cystic fibrosis transmembrane regulator (CFTR) gene in patients with obstructive azoospermia
AUTOR(ES)
Bernardino, Andrea L.F., Lima, Cintia E., Zatz, Mayana
FONTE
Genetics and Molecular Biology
DATA DE PUBLICAÇÃO
2003
RESUMO
Congenital bilateral absence of the vas deferens (CBAVD) accounts for 1%-2% of sterility in men. A high incidence of mutations, as well as the involvement of the 5T variant of the T tract length in intron 8 of the cystic fibrosis conductance regulator (CFTR) gene, have been previously described in males with CBAVD. Herein we report the screening for mutations and for the 5T variant of the CFTR gene in 17 patients with CBAVD and three others with non-CABVD obstructive azoospermia. In the CBAVD group, three patients (15%) were compound heterozygotes for mutations, and five patients (25%) had a mutation in one allele and the 5T variant in the other; the 5T variant was also present in two other patients, one of them being homozygous. The most frequent mutation was DF508, present on five chromosomes (12.5%). A novel missense mutation (A399D) was detected in a Japanese CBVAD patient. Our results yield further evidence for a strong association between male obstructive azoospermia caused by CBAVD and mutation/5T variant in the CFTR gene. The search for CFTR mutations in such patients is thus recommended for genetic counseling of couples who undergo assisted fertilization due to CBAVD.
Documentos Relacionados
- Cystic fibrosis transmembrane conductance regulator (CFTR) gene transcripts.
- The Cystic Fibrosis Transmembrane Regulator (CFTR) in the kidney
- Cystic fibrosis transmembrane conductance regulator (CFTR) is expressed in human bone
- 'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations
- Medical genetics: advances in brief: Omission of exon 12 in cystic fibrosis transmembrane conductance regulator (CFTR) gene transcripts